Parr McKnight Wealth Management Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.41M Buy
14,946
+1,177
+9% +$403K 0.64% 45
2026
Q1
$4.84M Sell
13,769
-1,066
-7% -$380K 0.64% 50
2025
Q4
$4.86M Sell
14,835
-125
-0.8% -$39.7K 0.64% 50
2025
Q3
$4.22M Sell
14,960
-23
-0.2% -$6.67K 0.55% 58
2025
Q2
$4.18M Buy
14,983
+1,490
+11% +$422K 0.57% 52
2025
Q1
$4.2M Sell
13,493
-883
-6% -$261K 0.6% 47
2024
Q4
$3.75M Buy
+14,376
New +$4.27M 0.54% 51

Other funds holding AMGN

Parr McKnight Wealth Management Group's AMGN Position: Q2 2026 in Review

Parr McKnight Wealth Management Group increased its Amgen (AMGN) stake by 8.5% in Q2 2026, buying an estimated $403K and bringing the position to 14,946 shares worth $5.41M. The position accounts for 0.64% of the portfolio, ranked #45.

Parr McKnight Wealth Management Group first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Parr McKnight Wealth Management Group held 14,946 shares of Amgen worth $5.41M as of Q2 2026.
  • Parr McKnight Wealth Management Group bought 1,177 Amgen shares in Q2 2026, an estimated $403K.
  • Amgen made up 0.64% of Parr McKnight Wealth Management Group's portfolio in Q2 2026, its #45 holding.
  • Parr McKnight Wealth Management Group first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Parr McKnight Wealth Management Group's 13F filing for Q2 2026, filed 5 Aug 2026.